MANNKIND CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.365 USD | -0.46% |
|
+6.46% | +47.12% |
| Jun. 22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
| May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 266.3 | 728 | 1,098 | 1,387 | 981.3 | 1,468 | - | - |
| Enterprise Value (EV) 1 | 266.3 | 728 | 1,098 | 1,387 | 679 | 1,468 | 1,468 | 1,468 |
| P/E ratio | -4.78 x | -12 x | -13.7 x | -15.5 x | -91 x | 46.9 x | 20.7 x | 12.3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 4.22 x | 11.2 x | 14.6 x | 13.9 x | 4.93 x | 5.39 x | 4.34 x | 3.59 x |
| EV / Revenue | 4.22 x | 11.2 x | 14.6 x | 13.9 x | 4.93 x | 5.39 x | 4.34 x | 3.59 x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | -118 x | 7.81 x | 11.6 x | 8.79 x |
| FCF Yield | - | - | - | - | -0.85% | 12.8% | 8.58% | 11.4% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 206,408 | 232,601 | 251,256 | 263,196 | 269,575 | 272,316 | - | - |
| Reference price 2 | 1.290 | 3.130 | 4.370 | 5.270 | 3.640 | 5.390 | 5.390 | 5.390 |
| Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 63.04 | 65.14 | 75.44 | 99.77 | 199 | 272.3 | 338.4 | 409.3 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -44.6 | -34.68 | -47.02 | -64.11 | 8.678 | 66.91 | 106.2 | 178.3 |
| Operating Margin | -70.75% | -53.24% | -62.33% | -64.26% | 4.36% | 24.57% | 31.37% | 43.56% |
| Earnings before Tax (EBT) 1 | -51.9 | -57.46 | -80.93 | -87.4 | -10.38 | 37.43 | 90.68 | 173.5 |
| Net income 1 | -51.9 | -57.24 | -80.93 | -87.4 | -11.94 | 35.41 | 84.83 | 146.8 |
| Net margin | -82.34% | -87.87% | -107.27% | -87.6% | -6% | 13% | 25.06% | 35.87% |
| EPS 2 | -0.2700 | -0.2600 | -0.3200 | -0.3400 | -0.0400 | 0.1150 | 0.2600 | 0.4400 |
| Free Cash Flow 1 | - | - | - | - | -8.347 | 188 | 126 | 167 |
| FCF margin | - | - | - | - | -4.2% | 69.04% | 37.23% | 40.8% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | 530.95% | 148.53% | 113.72% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.52 | 11.99 | 18.89 | 32.82 | 36.06 | 40.63 | 48.61 | 51.25 | 58.47 | 66.26 | 65.59 | 67.85 | 72.58 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -23.97 | -21.26 | -20.45 | -9.61 | -12.79 | -5.998 | 1.721 | 5.097 | 7.858 | 16.72 | 15.59 | 16.64 | 18.17 |
| Operating Margin | -191.51% | -177.25% | -108.26% | -29.28% | -35.47% | -14.76% | 3.54% | 9.94% | 13.44% | 25.24% | 23.76% | 24.53% | 25.04% |
| Earnings before Tax (EBT) 1 | -28.06 | -26 | -29.02 | -14.43 | -17.95 | -9.795 | -5.265 | 1.721 | 2.962 | 10.89 | 2.691 | 11.1 | 12.71 |
| Net income 1 | -28.06 | -26 | -29.02 | -14.43 | -17.95 | -9.795 | -5.265 | 1.721 | 1.401 | 10.63 | 1.818 | 10.68 | 12.13 |
| Net margin | -224.22% | -216.79% | -153.61% | -43.97% | -49.77% | -24.11% | -10.83% | 3.36% | 2.4% | 16.04% | 2.77% | 15.73% | 16.71% |
| EPS 2 | -0.1100 | -0.1000 | -0.1100 | -0.0600 | -0.0700 | -0.0400 | -0.0200 | 0.0100 | 0.004300 | 0.0400 | 0.007500 | 0.0350 | 0.0375 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/5/22 | 8/9/22 | 11/8/22 | 2/23/23 | 5/9/23 | 8/7/23 | 11/7/23 | 2/27/24 | 5/8/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | 302 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | - | -8.35 | 188 | 126 | 167 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 2.57 | 0.8 | 11.5 | 7.59 | 42.4 | 11 | 14 | 18 |
| Capex / Sales | 4.07% | 1.23% | 15.2% | 7.61% | 21.33% | 4.04% | 4.29% | 4.65% |
| Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.39
USD
Average target price
6.5
USD
Spread / Average Target
+20.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +47.12% | 1.47B | |
| +19.32% | 124B | |
| +20.00% | 114B | |
| +21.11% | 25.83B | |
| -23.80% | 19.42B | |
| -18.17% | 16.2B | |
| -19.59% | 15.31B | |
| +54.29% | 14.32B | |
| +8.13% | 14.31B | |
| -48.79% | 14.19B |
- Stock Market
- Equities
- MNKD Stock
- Financials MannKind Corporation
